Rocket Pharmaceuticals Inc. (RCKT) Fundamentals

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
SHARE INFORMATION
Market Cap$ 1,137,383,428
Shares Outstanding66,050,141
Float46,813,568
Percent Float70.88%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.67
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions404
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months6,446,020
Institutional Holdings Percent141.2%
Institutional Sold Previous 3 Months9,691,500
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months138,776
Insider Holdings Percent1.4
Insider Sold Previous 3 Months-
Insider Shares Owned921,094
TRADING INFO
52 Week High$ 36.87
52 Week Low$ 7.57
52 Week High Change$ -40.62
21 Day Moving Average$ 14.5157
21 Day Extended Moving Average$ 14.7835
50 Day Moving Average$ 15.4326
50 Day Extended Moving Average$ 14.9749
200 Day Moving Average$ 15.3534
200 Day Extended Moving Average$ 17.4863
10 Day Average Volume1,583,735
20 Day Average Volume1,514,581
30 Day Average Volume1,216,746
50 Day Average Volume1,008,586
Alpha0.021658
Beta1.4953
Standard Deviation0.210303
R20.137441
7 Day Price Change$ 3.74
7 Day Percent Change27.74%
21 Day Price Change$ 3.31
21 Day Percent Change23.8%
30 Day Price Change$ 1.68
30 Day Percent Change10.81%
Month to Date Price Change$ 1.26
Month to Date Percent Change7.89%
Quarter to Date Price Change$ 1.26
Quarter to Date Percent Change7.89%
180 Day Price Change$ 0.58
180 Day Percent Change3.49%
200 Day Price Change$ 1.28
200 Day Percent Change8.03%
Year to Date Price Change$ -4.61
Year to Date Percent Change-21.12%

Rocket Pharmaceuticals Inc. (RCKT) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.90
Total Debt To Equity0.10
Int Coverage-42.10
Current Ratio13.40
Leverage Ratio1.10
Quick Ratio13.20
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-5.20
Enterprise Value$ 724,674,185
Price to Sales0.00
Price to Free Cash-8.80
PE High Last 5 Years-3.80
Price To Book2.60
Price To Cash Flow0.00
PE Low Last 5 Years-8.30
Price to Tangible Book2.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-42.39
Return on Equity-46.76
Return on Capital-41.04

Rocket Pharmaceuticals Inc. (RCKT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorEisnerAmper LLP
CEOGaurav Shah
Emplyoees151
Last AuditUQ
CIK0001281895
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address9 Cedarbrook Drive
Suite 7530, The Empire State Building
Cranbury, NJ 8512
Websitehttp://www.rocketpharma.com
Facsimile+1 646 224-9585
Telephone+1 609 659-8001
Emailinvestors@rocketpharma.com


Your Recent History
NASDAQ
RCKT
Rocket Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.